NCT02378441View on ClinicalTrials.gov

Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

August 31, 2015

Conditions
Healthy
Interventions
DRUG

Atorvastatin 20mg and Metformin SR 750mg

co-administration of Atorvastatin 20mg and Metformin SR 750mg

DRUG

CJ-30056 20/750mg

fixed-dosed combination of Atorvastatin 20mg and Metformin SR 750mg

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT02378441 - Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg | Biotech Hunter | Biotech Hunter